Enterprise Value to EBITDA Multiple ratio Analysis of Janux Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-38748.35
Period Ending - Dec-22
Very Poor EV to EBITDA
-33.66
Growth
-115004.98 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-38.11
EV to EBITDA Analysis of Janux Therapeutics Inc
| EV to EBITDA Ratio of JANX drastically fell by -115004.98 % this year. |
| EV to EBITDA Ratio with value of -33.66 was highest in Year Dec-22 in last Five Years. |
| EV to EBITDA Ratio with value of -38748.35 was lowest in Year Dec-23 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -38748.35 is lower than Average EV to EBITDA of -7798.31 in last five years. |
Other EV to EBITDA Related Info of JANX that may interest you.
Janux Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| JANX | 53.5 | 50.41 | 6.13 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Janux Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
|---|---|---|---|---|---|
| EV to EBITDA | -38748.35 | -33.66 | -66.27 | -51.20 | -92.05 |
| Change | -115004.98 % | 49.21 % | -29.43 % | 44.37 % |
FY Chart of Enterprise Value to EBITDA Multiple of Janux Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)